title: [Fibrates: their prescription must be restricted].
authors.forename: Sophie
authors.initials: S
authors.lastname: Béliard-Lasserre
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D011307:Drug Prescriptions / Q000592:standards*; D011345:Fenofibrate / Q000627:therapeutic use; D058607:Fibric Acids / Q000009:adverse effects / Q000627:therapeutic use*; D005602:France; D015248:Gemfibrozil / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D010195:Pancreatitis / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents; D015248:Gemfibrozil; D011345:Fenofibrate